( December 16, 2024, 8:15 AM EST) -- PHILADELPHIA — A panel of the Third Circuit U.S. Court of Appeals affirmed dismissal of an investor’s securities fraud class action against a medical device manufacturer, agreeing with the trial court that the investor failed to plead falsity and scienter as to business statements the investor found to be misleading....